Niranjan Kanesa-thasan

A first-in-human Phase 1/1b randomized trial evaluating the safety and immunogenicity of a respiratory syncytial virus (RSV) virus-like particle subunit vaccine (IVX-121) in healthy young and older adults

Ilse De Coster, Isabel Leroux‐Roels, Kanchanamala Withanage, Leen Suykens et autres

be, br (code pays fourni par la source)

The Burden of Human Metapneumovirus (hMPV) Disease in Older and High-Risk Adults in Developed Countries: A Systematic Literature Review

Ajoke Sobanjo-ter Meulen, Ana Gutiérrez, Ornella Ruiz, Jennifer Eeuwijk et autres

ch, be, us (code pays fourni par la source)

Incidence of Human Metapneumovirus Among Older Adults in 10 High-Income Countries: A Systematic Literature Review, Meta-analysis, and Modeling Study

Jiali Lei, Christopher Gillespie, Serena Santoni, Jam Suba et autres

us, kr (code pays fourni par la source)

A Randomized Phase 1 Clinical Trial of a Respiratory Syncytial Virus and Human Metapneumovirus Combination Protein-Based Virus-like Particle Vaccine in Adults 60–75 Years of Age

Craig Shapiro, Nelia Sánchez-Crespo, Max Ciarlet, Nicholas Hourguettes et autres

us, ch (code pays fourni par la source)

P-601. Safety and Immunogenicity of a Respiratory Syncytial Virus and Human Metapneumovirus Virus-like Particle Protein Subunit Combination Vaccine in 60–85-Year-Old Adults: Interim Results from a Phase 2a Clinical Trial

Matthew Davis, Craig Shapiro, Mark D. Adams, Max Ciarlet et autres

us (code pays fourni par la source)

Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial

Zoe Moodie, Erica Andersen‐Nissen, Nicole Grunenberg, One Dintwe et autres

us, Afrique du Sud, Mozambique, Zimbabwe, be (code pays fourni par la source)

1955. Immunogenicity And Safety of a Virus-Like Particle (VLP) Protein Subunit SARS-CoV-2 Vaccine in Adults: a Phase 1/2 Study

Robert Scott, Susan Thackwray, Nicholas Hourguettes, Huub C. Gelderblom et autres

au (code pays fourni par la source)

Safety and immunogenicity of an inactivated eastern equine encephalitis virus vaccine

Benjamin C. Pierson, Anthony P. Cardile, Arthur C. Okwesili, Isaac Downs et autres

us (code pays fourni par la source)

Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120–MF59 in Adults

Glenda Gray, Linda‐Gail Bekker, Fatima Laher, Mookho Malahleha et autres

Afrique du Sud, us, it, be, ch (code pays fourni par la source)

Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients—a randomized clinical trial

Christopher Adlbrecht, Raphael Wurm, Pieter Depuydt, Herbert Spapen et autres

at, be, es, de, hu, cz, us (code pays fourni par la source)

Dupilumab is associated with lower rates of respiratory infections in patients with chronic rhinosinusitis with nasal polyps-Safety analysis from the SINUS-52 phase 3 trial

Claus Bachert, Philippe Gevaert, Niranjan Kanesa-thasan, Leda Mannent et autres

Safety, Tolerability and Immunogenicity of an MF59-adjuvanted, Cell Culture-derived, A/H5N1, Subunit Influenza Virus Vaccine: Results From a Dose-finding Clinical Trial in Healthy Pediatric Subjects

Pornthep Chanthavanich, Edwin L. Anderson, Phirangkul Kerdpanich, Michael Bulitta et autres

th, us, de (code pays fourni par la source)